Erste Asset Management’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1M | Hold |
73,100
| – | – | 0.01% | 505 |
|
|
2025
Q1 | $1.15M | Hold |
73,100
| – | – | 0.01% | 362 |
|
|
2024
Q4 | $1.05M | Buy |
73,100
+62,000
| +559% | +$887K | 0.01% | 381 |
|
|
2024
Q3 | $104K | Hold |
11,100
| – | – | ﹤0.01% | 493 |
|
|
2024
Q2 | $105K | Hold |
11,100
| – | – | ﹤0.01% | 490 |
|
|
2024
Q1 | $106K | Hold |
11,100
| – | – | ﹤0.01% | 489 |
|
|
2023
Q4 | $36.6K | Hold |
11,100
| – | – | ﹤0.01% | 516 |
|
|
2023
Q3 | $61.5K | Hold |
11,100
| – | – | ﹤0.01% | 509 |
|
|
2023
Q2 | $92.5K | Hold |
11,100
| – | – | ﹤0.01% | 520 |
|
|
2023
Q1 | $121K | Hold |
11,100
| – | – | ﹤0.01% | 524 |
|
|
2022
Q4 | $162K | Hold |
11,100
| – | – | ﹤0.01% | 517 |
|
|
2022
Q3 | $207K | Hold |
11,100
| – | – | ﹤0.01% | 496 |
|
|
2022
Q2 | $246K | Hold |
11,100
| – | – | 0.01% | 496 |
|
|
2022
Q1 | $208K | Hold |
11,100
| – | – | ﹤0.01% | 503 |
|
|
2021
Q4 | $227K | Hold |
11,100
| – | – | ﹤0.01% | 486 |
|
|
2021
Q3 | $251K | Hold |
11,100
| – | – | 0.01% | 463 |
|
|
2021
Q2 | $287K | Hold |
11,100
| – | – | 0.01% | 455 |
|
|
2021
Q1 | $299K | Buy |
+11,100
| New | +$299K | 0.01% | 427 |
|